Howard Capital Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,640
Closed -$219K 149
2025
Q2
$219K Sell
2,640
-865
-25% -$69K 0.02% 117
2025
Q1
$284K Sell
3,505
-250,661
-99% -$22.4M 0.02% 105
2024
Q4
$22.9M Buy
254,166
+6,052
+2% +$586K 1.57% 28
2024
Q3
$24.5M Buy
248,114
+6,188
+3% +$608K 1.72% 28
2024
Q2
$22.4M Buy
241,926
+12,271
+5% +$1.1M 1.65% 25
2024
Q1
$21.8M Buy
229,655
+5,431
+2% +$504K 1.68% 25
2023
Q4
$20M Buy
224,224
+7,365
+3% +$547K 1.74% 25
2023
Q3
$15.8M Buy
216,859
+7,431
+4% +$594K 1.53% 29
2023
Q2
$17.4M Buy
209,428
+5,134
+3% +$429K 1.62% 28
2023
Q1
$15.6M Sell
204,294
-1,292
-0.6% -$107K 1.65% 28
2022
Q4
$17.1M Buy
205,586
+1,619
+0.8% +$131K 2.05% 24
2022
Q3
$16.2M Sell
203,967
-77
-0% -$6.49K 2.04% 24
2022
Q2
$15.2M Buy
204,044
+5,086
+3% +$382K 1.78% 27
2022
Q1
$17.9M Buy
198,958
+5,724
+3% +$529K 1.63% 29
2021
Q4
$21.6M Buy
193,234
+7,665
+4% +$924K 1.79% 27
2021
Q3
$23.3M Buy
185,569
+7,465
+4% +$961K 2.16% 20
2021
Q2
$24.1M Buy
178,104
+6,270
+4% +$824K 2.27% 19
2021
Q1
$23.3M Buy
+171,834
New +$25.7M 2.44% 17

Other funds holding XBI

Howard Capital Management Group's XBI Position: Q3 2025 in Review

Howard Capital Management Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 2,640 shares — an estimated $219K sold.

Howard Capital Management Group first reported a position in XBI in Q1 2021 and held it in 18 quarters. The position peaked at $24.5M in Q3 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Howard Capital Management Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
  • Howard Capital Management Group sold 2,640 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $219K.
  • Howard Capital Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 18 quarters.
  • Howard Capital Management Group's State Street SPDR S&P Biotech ETF position peaked at $24.5M in Q3 2024.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Howard Capital Management Group's 13F filing for Q3 2025, filed 16 Oct 2025.